Special Report

Special Report By Nicholas St. Fleur

Chadwick Boseman’s tragedy is America’s tragedy: In colorectal cancer hot spots, young men are dying at higher rates

Prescription Politics By Lev Facher

More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows

Prescription Politics By Lev Facher

Pharma funded more than 2,400 state lawmaker campaigns in 2020, new STAT analysis finds

Special Report By Helen Branswell

As Covid dissipates in the U.S., cold and flu viruses may return with a vengeance

Special Report By Brent Crane — The Wire

At BGI, China’s genomics giant, the line between biotech and Beijing is increasingly blurry

Special Report By Olivia Goldhill

In Palm Beach, Covid-19 vaccines intended for rural Black communities are instead going to wealthy white Floridians

Special Report By Kate Sheridan

At Flagship Pioneering, the brazen venture capital firm that bankrolled Moderna, there’s a tolerance for failure but not for weakness

Special Report By Rachel Cohrs

Hospitals’ Covid-19 heroics have them poised for power in the new Washington

Special Report By Andrew Joseph

The coronavirus at 1: A year into the pandemic, what scientists know about how it spreads, infects, and sickens 

Special Report By Helen Branswell

The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them

Special Report By Damian Garde — STAT and Jonathan Saltzman — Boston Globe

The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race

Special Report By Erin Brodwin

Externally polished, internally marginalized: Inside the fight over Pinterest’s health misinformation policy

Special Report By Lev Facher

First-of-its-kind examination shows how widely pharma showers campaign cash at the state level

Special Report By Nicholas Florko

The 8 most important leaders of Operation Warp Speed

Special Report By Andrew Joseph

The Road Ahead: Charting the coronavirus pandemic over the next 12 months — and beyond

Special Report By Erin Brodwin and Rebecca Robbins

As Elon Musk’s Neuralink prepares to draw back the curtain, ex-employees describe rushed timelines clashing with science’s slow pace

Special Report By Lev Facher

Ramped-up testing and daily briefings: Inside Biden’s plan to take over a tumultuous Covid-19 response

Special Report By Rebecca Robbins and Erin Brodwin

How Teladoc won: The inside story of how well-timed bets propelled it ahead of the competition

Special Report By Rebecca Robbins and Adam Feuerstein

Harry Reid and Alex Trebek tried Patrick Soon-Shiong’s experimental cancer therapy. Can their results be duplicated in a clinical trial?

Special Report By Rebecca Robbins and Erin Brodwin

An invisible hand: Patients aren’t being told about the AI systems advising their care

Special Report By Nicholas Florko

The CDC has always been an apolitical island. That’s left it defenseless against Trump

Special Report By David Barboza — The Wire

After a bribery scandal in China, GSK found a suspected whistleblower. The real one is still waiting in the shadows

Special Report By Megan Thielking

Facing a broken mental health system, many U.S. teens fall off a dangerous ‘cliff’ in their care

Special Report By Erin Brodwin and Casey Ross

Two years of halting progress and high turnover preceded Atul Gawande’s exit as Haven CEO

Special Report By Nicholas Florko and Damian Garde

With remdesivir, Gilead finds itself at strategic crossroads, with its reputation (and far more) at stake